Schonfeld Strategic Advisors LLC Castle Biosciences Inc Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 56,000 shares of CSTL stock, worth $1.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
56,000
Previous 51,247 9.27%
Holding current value
$1.58 Million
Previous $1.12 Million 43.23%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$17.4 - $31.47 $82,702 - $149,576
4,753 Added 9.27%
56,000 $1.6 Million
Q2 2024

Aug 14, 2024
SELL
$18.84 - $24.94 $2.15 Million - $2.85 Million
-114,194 Reduced 69.02%
51,247 $1.12 Million
Q1 2024

May 15, 2024
BUY
$18.06 - $25.3 $74,786 - $104,767
4,141 Added 2.57%
165,441 $3.66 Million
Q4 2023

Feb 14, 2024
BUY
$12.19 - $22.43 $161,761 - $297,646
13,270 Added 8.96%
161,300 $3.48 Million
Q3 2023

Nov 14, 2023
BUY
$13.28 - $20.3 $1.47 Million - $2.24 Million
110,500 Added 294.43%
148,030 $2.5 Million
Q2 2023

Aug 14, 2023
BUY
$11.66 - $26.0 $137,424 - $306,436
11,786 Added 45.78%
37,530 $514,000
Q1 2023

May 15, 2023
SELL
$19.47 - $28.49 $617,491 - $903,560
-31,715 Reduced 55.2%
25,744 $584,000
Q4 2022

Feb 14, 2023
SELL
$18.08 - $30.0 $1.97 Million - $3.27 Million
-108,935 Reduced 65.47%
57,459 $1.35 Million
Q3 2022

Nov 14, 2022
SELL
$22.51 - $34.32 $30,816 - $46,984
-1,369 Reduced 0.82%
166,394 $4.34 Million
Q2 2022

Aug 15, 2022
BUY
$16.0 - $45.99 $1.7 Million - $4.88 Million
106,059 Added 171.88%
167,763 $3.68 Million
Q1 2022

May 16, 2022
BUY
$33.17 - $46.98 $682,970 - $967,318
20,590 Added 50.08%
61,704 $2.77 Million
Q4 2021

Feb 14, 2022
SELL
$39.06 - $67.58 $196,159 - $339,386
-5,022 Reduced 10.89%
41,114 $1.76 Million
Q3 2021

Nov 16, 2021
BUY
$60.13 - $77.6 $1.13 Million - $1.45 Million
18,723 Added 68.3%
46,136 $3.07 Million
Q2 2021

Nov 16, 2021
SELL
$50.07 - $76.78 $424,944 - $651,631
-8,487 Reduced 23.64%
27,413 $2.01 Million
Q2 2021

Aug 16, 2021
BUY
$50.07 - $76.78 $419,035 - $642,571
8,369 Added 30.4%
35,900 $2.63 Million
Q1 2021

May 17, 2021
BUY
$58.92 - $97.33 $1.15 Million - $1.9 Million
19,531 Added 244.14%
27,531 $1.89 Million
Q4 2020

Feb 16, 2021
SELL
$43.6 - $73.05 $3.08 Million - $5.16 Million
-70,700 Reduced 89.83%
8,000 $538,000
Q3 2020

Nov 16, 2020
BUY
$38.47 - $52.03 $2.43 Million - $3.29 Million
63,200 Added 407.74%
78,700 $4,000
Q2 2020

Aug 14, 2020
BUY
$27.28 - $43.01 $422,840 - $666,655
15,500 New
15,500 $584,000

Others Institutions Holding CSTL

# of Institutions
202
Shares Held
26M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $740M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email